SXTPW
60 Degrees Pharmaceuticals Inc. Warrant
$0.052+0.000 (0.000%)
即時價格
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$0.000
最高
$0.000
最低
$0.000
交易量
0.00M
公司基本面
交易統計
相關新聞
GlobeNewswire
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals
25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000A full 45 percent of persistent babesiosis cases include chronic fatigueHealthcare providers treating
查看更多
GlobeNewswire
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results
Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand.Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP;
查看更多
